Tetanus Toxoid Diagnostic Antigen from Japan
Tetanus toxoid antigens for skin testing immune status in patients. This product is under HTS 3006.30.10.00 as a diagnostic reagent with antigens in measured doses for patient administration. Confirms antibody response prior to booster vaccination.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include Lf (Limesflocculation) unit standardization certificates
• Safety-tested for hypersensitivity; provide clinical safety data
• Declare as 'skin test diagnostic' vs therapeutic toxoid vaccine